The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

CBRE Group, Inc.

Related Interviews

Commercial Real Estate Services Companies Are Monetizing Change
May 15, 2022
Sheldon, Stephen

Delivering Alpha Through a Balance Sheet-Driven Process
May 06, 2021
VanCronkhite, Bryant

Identifying Intrinsic Value Key to Stock Selection
December 17, 2020
Nicolas, Michael

Attractive Opportunities in the Subsectors That Have Sold Off the Most
May 08, 2020
Hafuda, Yousuf, Brown, Kevin

Real Estate Tech Companies with Mission-Critical Solutions Are Well-Positioned
May 08, 2020
Sheldon, Stephen

Stock Performance for REITs Will Be Driven by Macro Factors in 2019
May 10, 2019
Paolone, Anthony

Finding Opportunities to Buy Great Businesses as Volatility Increases
September 07, 2018
Dunbar, McGavock

Interest Rates Directly Impact Demand in Real Estate Subsectors
April 26, 2018
Rahmani, Jade

A More Conducive Environment for REITs
August 11, 2017
Paolone, Anthony

Using Intangible Assets to Identify Undervalued Stocks
March 24, 2017
Dhingra, Gautam

Organic Growth, Acquisitions and Development Drive Earnings Growth for REITs
May 20, 2013

OUTLOOK FOR NORTHEAST BANKS - CHRISTOPHER MARINAC - FIG PARTNERS, LLC
October 22, 2007

SMALL CAP GROWTH INVESTING - JAMES A. BITZER - EGM CAPITAL, LLC
December 04, 2006

BRIAN KRAWEZ - BELDEN & ASSOCIATES
June 26, 2006

W.MORRILL JR. / D.OLIVER - BROWN INVESTMENT ADVISORY
January 31, 2005

Insurance Brokers : Gary K. Ransom - Conning & Company
June 28, 1999

James M. Hussey - Neopharm Inc (neo)
April 20, 1998

Cart

Latest News

Gilead (GILD) is a Biotech Bottom Buy According to Hartaj Singh of Oppenheimer & Company
Hitachi, Sony, Mitsubishi, Tokio Marine, and Keyence: a Japanese Stock Portfolio
Walmart (WMT) is an Undervalued Real Estate Play and So Is the New York Times (NYT)

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Interview with the Executive Chairman, Interim CEO and Chief Scientific Officer: RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI)

Arnold Lippa

Published August 18, 2022 in Biotechnology and Pharmaceuticals

Companies covered: RSPI

Buy ($25)

Interview with the Co-Founder, President and CEO: Equillium Inc. (NASDAQ:EQ)

Bruce Steel

Published August 18, 2022 in Biotechnology and Pharmaceuticals

Companies covered: EQ

Buy ($25)

Interview with the CEO: Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

Adrian Rawcliffe

Published August 18, 2022 in Biotechnology and Pharmaceuticals

Companies covered: ADAP

Buy ($25)

Most Popular Reports

Biotechnology and Pharmaceuticals

Published August 18, 2022

Buy ($175)

Investing Strategies

Published August 04, 2022

Buy ($175)

Banks

Published August 01, 2022

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Bank of America Corporation
Exxon Mobil Corporation
Dell Inc.
Verizon Communications Inc.
AT&T Inc.

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Executive Chairman, Interim CEO and Chief Scientific Officer: RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI)
Interview with the Co-Founder, President and CEO: Equillium Inc. (NASDAQ:EQ)
Interview with the CEO: Adaptimmune Therapeutics PLC (NASDAQ:ADAP)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Negative Consumer Sentiment Is Actually a Bullish Indicator
3 Great Companies Finally Cheap Enough to Buy
Creating a Platform That Lets Financial Advisers Do It Their Way
ANALYST INTERVIEWS
Innovative New Cell and Gene Therapies Show Transformative Benefits
Sizing Up Risk Across the Biotech Cap Spectrum
Biotechs Hit Bottom and Bounce Back — Twice
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2022
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google